StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.14+0.06 (+2.88%)

Close on Nov 17, 2026Market cap $36.49MP/E –Yield –

Veru total assets

Total assets on the balance sheet at the end of each period.

Veru's total assets was $37.03M at Jun 30, 2026. For fiscal 2025 it was $29.84M, down 50.6% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $178.15M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Sep 30, 2025$29.84M-50.6%
FY2024Sep 30, 2024$60.42M+20.8%
FY2023Sep 30, 2023$50.02M-63.0%
FY2022Sep 30, 2022$135.36M-24.0%
FY2021Sep 30, 2021$178.15M+245.6%
FY2020Sep 30, 2020$51.54M-3.9%
FY2019Sep 30, 2019$53.63M+10.7%
FY2018Sep 30, 2018$48.45M-12.4%
FY2017Sep 30, 2017$55.34M+43.3%
FY2016Sep 30, 2016$38.62M+3.1%
FY2015Sep 30, 2015$37.47M+18.3%
FY2014Sep 30, 2014$31.67M-9.9%
FY2013Sep 30, 2013$35.17M+15.5%
FY2012Sep 30, 2012$30.45M+56.6%
FY2011Sep 30, 2011$19.44M+5.9%
FY2010Sep 30, 2010$18.37M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026$37.03M+35.5%
Q2 FY2026CQ1 2026Mar 31, 2026$43.08M+31.9%
Q1 FY2026CQ4 2025Dec 31, 2025$47.57M+19.4%
Q4 FY2025CQ3 2025Sep 30, 2025$29.84M-50.6%
Q3 FY2025CQ2 2025Jun 30, 2025$27.33M-57.7%
Q2 FY2025CQ1 2025Mar 31, 2025$32.67M-54.5%
Q1 FY2025CQ4 2024Dec 31, 2024$39.83M-50.6%
Q4 FY2024CQ3 2024Sep 30, 2024$60.42M+20.8%
Q3 FY2024CQ2 2024Jun 30, 2024$64.63M+7.4%
Q2 FY2024CQ1 2024Mar 31, 2024$71.80M+2.1%
Q1 FY2024CQ4 2023Dec 31, 2023$80.57M-20.4%
Q4 FY2023CQ3 2023Sep 30, 2023$50.02M-63.0%
Q3 FY2023CQ2 2023Jun 30, 2023$60.20M-62.5%
Q2 FY2023CQ1 2023Mar 31, 2023$70.34M-59.3%
Q1 FY2023CQ4 2022Dec 31, 2022$101.27M-41.2%
Q4 FY2022CQ3 2022Sep 30, 2022$135.36M-24.0%
Q3 FY2022CQ2 2022Jun 30, 2022$160.58M-10.8%
Q2 FY2022CQ1 2022Mar 31, 2022$172.83M-4.6%
Q1 FY2022CQ4 2021Dec 31, 2021$172.16M+136.5%
Q4 FY2021CQ3 2021Sep 30, 2021$178.15M+245.6%
Q3 FY2021CQ2 2021Jun 30, 2021$180.07M+176.2%
Q2 FY2021CQ1 2021Mar 31, 2021$181.15M+224.2%
Q1 FY2021CQ4 2020Dec 31, 2020$72.79M+33.5%
Q4 FY2020CQ3 2020Sep 30, 2020$51.54M-3.9%
Q3 FY2020CQ2 2020Jun 30, 2020$65.19M+21.1%
Q2 FY2020CQ1 2020Mar 31, 2020$55.88M+9.5%
Q1 FY2020CQ4 2019Dec 31, 2019$54.54M+4.2%
Q4 FY2019CQ3 2019Sep 30, 2019$53.63M+10.7%
Q3 FY2019CQ2 2019Jun 30, 2019$53.84M+0.7%
Q2 FY2019CQ1 2019Mar 31, 2019$51.01M-12.3%
Q1 FY2019CQ4 2018Dec 31, 2018$52.33M+2.5%
Q4 FY2018CQ3 2018Sep 30, 2018$48.45M-12.4%
Q3 FY2018CQ2 2018Jun 30, 2018$53.47M-6.9%
Q2 FY2018CQ1 2018Mar 31, 2018$58.20M+1.8%
Q1 FY2018CQ4 2017Dec 31, 2017$51.05M-15.7%
Q4 FY2017CQ3 2017Sep 30, 2017$55.34M+43.3%
Q3 FY2017CQ2 2017Jun 30, 2017$57.43M–
Q2 FY2017CQ1 2017Mar 31, 2017$57.18M–
Q1 FY2017CQ4 2016Dec 31, 2016$60.56M–
Q4 FY2016CQ3 2016Sep 30, 2016$38.62M–

More Veru figures

See a number that looks wrong?